Findings of a phase 2 trial with aldosteron synthase inhibitor in hypertension - PACE-CME

Findings of a phase trial with aldosteron synthase inhibitor in hypertension

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Imaging study with PCSK9 inhibitor in patients with stable CAD
Imaging study with PCSK9 inhibitor in patients with stable CAD
ACC.23
Imaging study with PCSK9 inhibitor in patients with stable CAD
- Annapoorna Kini, MD
A wearable device using infrared spectrophotometry to detect troponin I
A wearable device using infrared spectrophotometry to detect troponin I
ACC.23
A wearable device using infrared spectrophotometry to detect troponin I
- Prof. Partho Sengupta, MD
Interesting developments in the field of PCSK9 inhibition
Interesting developments in the field of PCSK9 inhibition
ACC.23
Interesting developments in the field of PCSK9 inhibition
- Deepak Bhatt, MD
Causal AI can substantially improve the value of polygenic risk score for CVD
Causal AI can substantially improve the value of polygenic risk score for CVD
ACC.23
Causal AI can substantially improve the value of polygenic risk score for CVD
- Prof. Brian Ference, MD